{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:22Z","timestamp":1793079142451,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yebeh.2026.111298","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:28:24Z","timestamp":1790450904000},"page":"111298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Short-Term psychiatric stability after brivaracetam initiation in patients with Epilepsy: A prospective Observational study"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0965-5092","authenticated-orcid":false,"given":"Mihoko","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Goji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111298_b0005","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1212\/CPJ.0000000000000874","article-title":"Psychiatric comorbidities in people with epilepsy","volume":"11","author":"Mula","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.yebeh.2026.111298_b0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2024.3976","article-title":"Psychiatric comorbidities in persons with epilepsy compared with persons without epilepsy: a systematic review and meta-analysis","volume":"82","author":"Kwon","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2026.111298_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/CON.0000000000001123","article-title":"Neuropsychiatric and cognitive comorbidities in epilepsy","volume":"28","author":"Mula","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2026.111298_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0025","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2174\/1570159X20666220526144314","article-title":"Optimization of therapy in patients with epilepsy and psychiatric comorbidities: key points","volume":"21","author":"Pisani","year":"2023","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2026.111298_b0030","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.yebeh.2026.111298_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107939","article-title":"Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review","volume":"118","author":"Steinhoff","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0040","article-title":"Aggression as psychiatric side effect of newer AEDs in patients with epilepsy: cross-sectional study based on Buss-Perry Aggression Questionnaire","volume":"118","author":"Kawai","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0045","first-page":"1","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein","year":"2018","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2026.111298_b0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40263-023-01033-4","article-title":"Effectiveness and tolerability of 12-month brivaracetam in the real world: EXPERIENCE, an international pooled analysis of individual patient records","volume":"37","author":"Villanueva","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2026.111298_b0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The aggression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.yebeh.2026.111298_b0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4992\/jjpsy.70.384","article-title":"Development of the Japanese version of the Buss-Perry Aggression Questionnaire (BAQ)","volume":"70","author":"Ando","year":"1999","journal-title":"Jpn J Psychol"},{"key":"10.1016\/j.yebeh.2026.111298_b0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2026.111298_b0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2012.06.015","article-title":"Screening for major depressive episodes in Japanese patients with epilepsy: validation and translation of the Japanese version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)","volume":"25","author":"Tadokoro","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.yebeh.2026.111298_b0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.sleep.2008.04.015","article-title":"Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory","volume":"10","author":"Takegami","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.yebeh.2026.111298_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.seizure.2024.02.022","article-title":"Psychiatric assessment prior to and after switch from levetiracetam to brivaracetam","volume":"117","author":"Kassoum","year":"2024","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111298_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2019.02.009","article-title":"The effect of perampanel on aggression and depression in patients with epilepsy: a short-term prospective study","volume":"67","author":"Goji","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111298_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108493","article-title":"Differences in aggression as psychiatric side effect of levetiracetam and perampanel in patients with epilepsy","volume":"126","author":"Kawai","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109844","article-title":"Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures","volume":"156","author":"Meador","year":"2024","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111298_b0110","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/epi.13054","article-title":"Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel","volume":"56","author":"Ettinger","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111298_b0115","article-title":"Brivaracetam-associated manic episode in a patient with bipolar disorder: a case report","volume":"5","author":"Kawai","year":"2026","journal-title":"Psychiatry Clin Neurosci Rep"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:38:28Z","timestamp":1793075908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026004191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":23,"alternative-id":["S1525505026004191"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111298","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-Term psychiatric stability after brivaracetam initiation in patients with Epilepsy: A prospective Observational study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111298"}}